Acquisition to be value- and earnings-accretive; FY21-23e ports Ebitda up 10-25%; TP raised to Rs 435 from Rs 400; ‘Buy’…
While FY22 recovery hopes are intact, recent euphoria worrisome in the near term; LTTS downgraded to ‘Hold’
Revival in sales better than expected; sharp growth rebound likely; valuation is appealing; Buy retained with revised TP of Rs…
Operating leverage likely to boost margins; rise in first-time buyers a positive; upgraded to ‘Buy’ with TP up to Rs…
Journey to normalcy is on track; despite crisis, likely to gain market share; ‘Buy’ retained with TP of Rs 860
Growth outlook is gradually improving on healthy agri sector demand; other segments likely to follow.
Despite initial volume curbs, Revlimid to be a meaningful opportunity; FY21-23e EPS up 1-3%; TP raised to Rs 5,400
PE investment in line with intent to induct partners in retail business; no major catalysts visible over next six months;…
Right execution should help bag good market share; firm likely to gain from push for biosimilars; ‘Buy’ retained
The exit of Future Group is indeed an industry-shaping event and one that highlights that winners will be few even though the opportunity…
TP raised to Rs 2,810 due to rise in Zomato valuation; need for caution; ‘Hold’ retained
Net NPAs moderated q-o-q; outlook is uncertain with few buffers; ‘Hold’ retained given inexpensive valuation
Execution key for recovery; FY21-23e EPS up 11-12% on current outlook; TP raised to Rs 500; ‘Hold’ maintained
Better days ahead; present valuations are unjustified given the prospects; ‘Buy’ retained with TP of Rs 230
In the notes to accounts to its Q1FY21 results, CCRI highlighted that it had received a demand of Rs 7.8bn…
Retain ‘hold’ and raise TP to Rs 2,755 (from Rs 2,135); key upside risk is benefits from supply of Covid-19…
The company plans to increase liquidity by Rs 50-60 billion by deferring rentals, cutting costs and through the sale and…
Subsidiaries performed better than expected; BS continued to deteriorate; valuations are stretched; ‘Reduce’ maintained.
